Our data showed that UTI upregulated the mRNA expression of SLC7A11 in a dose-dependent manner in LPS-treated podocyte at 48 h, in which 100 U/mL UTI presented the highest effect and was selected in the subsequent analysis (Fig. 1A). This evidence concerns the gene SLC7A11 and bacterial urinary tract infection.